Pharmos (PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote ()	2/11/2000 9:38:00 AM
From: leigh aulper	Read Replies (1) of 1386

SmallCaps Online LLC announced today that it has reiterated its BUY recommendation on Pharmos Corporation (NASDAQ:PARS - news) and set a 12-month price target of $7 to $9 per share and issued its full-length research report including a detailed earnings model. The full text of this report can be accessed at SmallCaps Online's web site, at www.SmallCapsOnline.com. SmallCaps Online LLC is registered as a broker-dealer with the Securities and Exchange Commission, the National Association of Securities Dealers, Inc., and the State of New York. SmallCaps Online LLC is focused on identifying emerging growth companies in the healthcare and information technology sectors that offer compelling investment opportunities over the long term. By providing comprehensive financial services, including corporate finance, M&A advisory, strategic partnering and communications consulting, the company positions itself to provide a fully integrated package of value-added services to emerging growth companies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next